Skip to main content
Premium Trial:

Request an Annual Quote

Roche Diagnostics Says Judge Ruled Against Enzo in Diagnostic Case

NEW YORK (GenomeWeb News) - Roche Diagnostics today said that a New York district judge ruled in its favor on key aspects of Enzo Biochem's patent-infringement case against the company.
 
According to Roche, the judge adopted "virtually all" of the interpretations proposed by Roche and its co-parties relating to seven Enzo patents.
 
Enzo earlier this week claimed the judge supported its patent-infringement claims against Affymetrix, Roche, Amersham, PerkinElmer, Sigma Aldrich, Orchid Biosciences, and Molecular Probes.
 
The litigation, first filed in 2002, concerns products and techniques for detecting genetic information in biological samples, such as blood. Enzo claimed Roche's AmpliChip CYP450 Test infringed its patent covering the "soluble signal" and the testing format.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more